Xeris Biopharma Holdings, Inc. (XERS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.59
Day's range
$5.82

Xeris Biopharma Holdings Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 12.95 M $75.09 M   2.42% 7.59%
D. E. SHAW & CO., INC. 05/15/2026 7.79 M $45.18 M   2.82% 4.57%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 6.98 M $40.49 M   100.00% 4.09%
STATE STREET CORP 05/15/2026 4.66 M $27.02 M   13.15% 2.73%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 4.29 M $24.89 M   0.34% 2.52%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 4.11 M $23.86 M   17.62% 2.41%
ROSALIND ADVISORS, INC. 05/14/2026 3.23 M $18.74 M   53.04% 1.90%
NUVEEN, LLC 04/30/2026 2.92 M $16.92 M   3.91% 1.71%
05/15/2026 2.67 M $15.46 M   100.00% 1.56%
MORGAN STANLEY 05/15/2026 2.57 M $14.92 M   -4.99% 1.51%
MILLENNIUM MANAGEMENT LLC 05/15/2026 2.27 M $13.14 M   163.78% 1.33%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 2.17 M $12.59 M   -5.04% 1.27%
TWO SIGMA INVESTMENTS, LP 05/15/2026 1.92 M $11.16 M   11.05% 1.13%
ARMISTICE CAPITAL, LLC 05/15/2026 1.91 M $11.08 M   100.00% 1.12%
LEGAL & GENERAL GROUP PLC 05/08/2026 1.91 M $11.07 M   36.67% 1.12%
PARKMAN HEALTHCARE PARTNERS LLC 05/15/2026 1.72 M $9.98 M   1.75% 1.01%
UBS GROUP AG 05/05/2026 1.65 M $9.55 M   173.56% 0.97%
GOLDMAN SACHS GROUP INC 05/15/2026 1.61 M $9.36 M   2.88% 0.95%
NORTHERN TRUST CORP 05/14/2026 1.44 M $8.38 M   4.17% 0.85%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 1.39 M $8.09 M   45.61% 0.82%
VOSS CAPITAL, LLC 05/15/2026 1.39 M $8.04 M   273.12% 0.81%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 1.36 M $7.89 M   -3.15% 0.80%
CENTERBOOK PARTNERS LP 05/05/2026 1.25 M $7.24 M   -10.27% 0.73%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2026 1.24 M $7.20 M   2.20% 0.73%
ALGERT GLOBAL LLC 05/14/2026 1.16 M $6.71 M   60.95% 0.68%
VANGUARD FIDUCIARY TRUST CO 05/15/2026 1.13 M $6.58 M   100.00% 0.67%
KNOTT DAVID M JR 05/14/2026 1.06 M $6.15 M   9.28% 0.62%
05/15/2026 1.03 M $5.95 M   28.13% 0.60%
GRANAHAN INVESTMENT MANAGEMENT, LLC 05/15/2026 921.85 K $5.35 M   -24.65% 0.54%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 902.74 K $5.24 M   -69.71% 0.53%
BANK OF AMERICA CORP /DE/ 05/18/2026 874.40 K $5.07 M   21.80% 0.51%
FEDERATED HERMES, INC. 05/11/2026 856.81 K $4.97 M   0.23% 0.50%
TREXQUANT INVESTMENT LP 05/15/2026 833.22 K $4.83 M   290.12% 0.49%
ESSEX INVESTMENT MANAGEMENT CO LLC 05/11/2026 747.77 K $4.34 M   1.80% 0.44%
JANE STREET GROUP, LLC 05/12/2026 725.62 K $4.21 M   308.06% 0.43%
CITADEL ADVISORS LLC 05/15/2026 681.63 K $3.95 M   66.33% 0.40%
UBS ASSET MANAGEMENT AMERICAS INC 05/13/2026 668.07 K $3.87 M   2.55% 0.39%
VOYA INVESTMENT MANAGEMENT LLC 05/12/2026 625.31 K $3.63 M   36.43% 0.37%
DEUTSCHE BANK AG\ 05/06/2026 623.01 K $3.61 M   -33.76% 0.37%
SQUAREPOINT OPS LLC 05/15/2026 614.55 K $3.56 M   27.28% 0.36%
JPMORGAN CHASE & CO 05/13/2026 612.48 K $3.43 M   -31.57% 0.36%
SEI INVESTMENTS CO 05/13/2026 579.21 K $3.36 M   45.04% 0.34%
FMR LLC 05/15/2026 513.08 K $2.98 M   16.69% 0.30%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 05/14/2026 464.08 K $2.69 M   -13.66% 0.27%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 452.86 K $2.63 M   -26.92% 0.27%
CAPTION MANAGEMENT, LLC 05/15/2026 443.50 K $2.57 M   100.00% 0.26%
BANK OF NEW YORK MELLON CORP 05/05/2026 426.29 K $2.47 M   -1.84% 0.25%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 407.63 K $2.36 M   -61.50% 0.24%
CAPTION MANAGEMENT, LLC 05/15/2026 403.40 K $2.34 M   226.90% 0.24%
RUSSELL INVESTMENTS GROUP, LTD. 05/08/2026 384.20 K $2.23 M   5.32% 0.23%

Xeris Biopharma Holdings Inc institutional Ownership - FAQ's

During the previous two years, 291 institutional investors and hedge funds held shares of Xeris Biopharma Holdings Inc. The most heavily invested institutionals were:

ESSEX INVESTMENT MANAGEMENT CO LLC: 715,608

Walleye Capital LLC: 611,296

Bank of New York Mellon Corp: 488,441

Russell Investments Group, Ltd.: 440,731

Y-Intercept (Hong Kong) Ltd: 411,346

Legato Capital Management LLC: 241,341

63.39% of Xeris Biopharma Holdings Inc stock is owned by institutional investors.

Institutional investors have bought a total of 122.57 M shares in the last 24 months. This purchase volume represents approximately $686.42 M in transactions.